FoxBio Company
FoxBio is a Company that will develop Antoxerene’s collection of small molecules that target senescent cells.
%20.jpg)
Last Funding Type:
Venture - Series Unknown
Headquarters:
Lafayette, Louisiana, United States
Founded Date:
2018
Investor Type:
Company
Last Funding Date:
2018
Total Funding:
10000000
Technology:
Geroscience
Number Of Exists:
Venture - Series Unknown
Investors Number:
2
Industry:
Biopharma, Biotechnology, Life Science